{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:59:47Z","timestamp":1788886787624,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Thailand Science Research and Innovation (TSRI), National Science, Research, and Innovation Fund","award":["195616"],"award-info":[{"award-number":["195616"]}]},{"name":"Thailand Science Research and Innovation (TSRI), National Science, Research, and Innovation Fund","award":["195616"],"award-info":[{"award-number":["195616"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11060-025-05219-2","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:24:37Z","timestamp":1757924677000},"page":"1091-1102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Piperlongumine induces meningioma cell death via the ROS-mediated endoplasmic reticulum stress and the alteration of the ubiquitin-proteasome system"],"prefix":"10.1007","volume":"175","author":[{"given":"Nopporn","family":"Naewwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krajang","family":"Talabnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanawat","family":"Trasaktaweesakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phattrara","family":"Khuansonthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pundit","family":"Asavaritikrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitchanun","family":"Jaturutthaweechot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutima","family":"Talabnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"10","key":"5219_CR1","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","volume":"26","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR et al (2024) Meningioma: international consortium on meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neurooncol 26(10):1742\u20131780. https:\/\/doi.org\/10.1093\/neuonc\/noae082","journal-title":"Neurooncol"},{"issue":"Suppl 5","key":"5219_CR2","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro-oncology 24(Suppl 5):v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro-oncology"},{"issue":"11","key":"5219_CR3","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/cancers15112945","volume":"15","author":"E Marastoni","year":"2023","unstructured":"Marastoni E, Barresi V (2023) Meningioma grading beyond histopathology: relevance of epigenetic and genetic features to predict clinical outcome. Cancers 15(11):2945. https:\/\/doi.org\/10.3390\/cancers15112945","journal-title":"Cancers"},{"issue":"11","key":"5219_CR4","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neurooncol 23(11):1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neurooncol"},{"issue":"6","key":"5219_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/neuonc\/noab015","volume":"23","author":"M Yamamoto","year":"2021","unstructured":"Yamamoto M, Sanomachi T, Suzuki S et al (2021) Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma. Neurooncol 23(6):945\u2013954. https:\/\/doi.org\/10.1093\/neuonc\/noab015","journal-title":"Neurooncol"},{"issue":"2","key":"5219_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/cancers15020483","volume":"15","author":"A Shahbandi","year":"2023","unstructured":"Shahbandi A, Shah DS, Hadley CC, Patel AJ (2023) The role of pharmacotherapy in treatment of meningioma: a systematic review. Cancers 15(2):483. https:\/\/doi.org\/10.3390\/cancers15020483","journal-title":"Cancers"},{"issue":"7","key":"5219_CR7","doi-asserted-by":"publisher","first-page":"e2300768","DOI":"10.1002\/ardp.202300768","volume":"357","author":"SS Swain","year":"2024","unstructured":"Swain SS, Sahoo SK (2024) Piperlongumine and its derivatives against cancer: a recent update and future prospective. Arch Pharm 357(7):e2300768. https:\/\/doi.org\/10.1002\/ardp.202300768","journal-title":"Arch Pharm"},{"issue":"4","key":"5219_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.37349\/etat.2021.00049","volume":"2","author":"D Parama","year":"2021","unstructured":"Parama D, Rana V, Girisa S et al (2021) The promising potential of Piperlongumine as an emerging therapeutics for cancer. Explor Target Anti-Tumor Ther 2(4):323\u2013354. https:\/\/doi.org\/10.37349\/etat.2021.00049","journal-title":"Explor Target Anti-Tumor Ther"},{"issue":"1","key":"5219_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41420-023-01672-y","volume":"9","author":"C Qiu","year":"2023","unstructured":"Qiu C, Shen X, Lu H et al (2023) Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells. Cell Death Discov 9(1):375. https:\/\/doi.org\/10.1038\/s41420-023-01672-y","journal-title":"Cell Death Discov"},{"key":"5219_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202500592","author":"N Sharma","year":"2025","unstructured":"Sharma N, Gupta M, Guleria M et al (2025) Endoplasmic reticulum stress and liver cancer: regulation through natural products. Chem Biodivers. https:\/\/doi.org\/10.1002\/cbdv.202500592","journal-title":"Chem Biodivers"},{"issue":"6","key":"5219_CR11","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2023.5318","volume":"52","author":"SJ Jeon","year":"2023","unstructured":"Jeon SJ, Choi EY, Han EJ et al (2023) Piperlongumine induces apoptosis via the MAPK pathway and ERKmediated autophagy in human melanoma cells. Int J Mol Med 52(6):115. https:\/\/doi.org\/10.3892\/ijmm.2023.5318","journal-title":"Int J Mol Med"},{"issue":"11","key":"5219_CR12","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10495-017-1422-y","volume":"22","author":"S Thongsom","year":"2017","unstructured":"Thongsom S, Suginta W, Lee KJ, Choe H, Talabnin C (2017) Piperlongumine induces G2\/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway. Apoptosis: Int J Program Cell Death 22(11):1473\u20131484. https:\/\/doi.org\/10.1007\/s10495-017-1422-y","journal-title":"Apoptosis: Int J Program Cell Death"},{"issue":"45","key":"5219_CR13","doi-asserted-by":"publisher","first-page":"73497","DOI":"10.18632\/oncotarget.11988","volume":"7","author":"Y Yao","year":"2016","unstructured":"Yao Y, Sun Y, Shi M et al (2016) Piperlongumine induces apoptosis and reduces bortezomib resistance by inhibiting STAT3 in multiple myeloma cells. Oncotarget 7(45):73497\u201373508. https:\/\/doi.org\/10.18632\/oncotarget.11988","journal-title":"Oncotarget"},{"issue":"1","key":"5219_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00210-022-02305-4","volume":"396","author":"N Naradun","year":"2023","unstructured":"Naradun N, Talabnin K, Ayuttha K, Talabnin C (2023) Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress-induced cell death. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 396(1):109\u2013120. https:\/\/doi.org\/10.1007\/s00210-022-02305-4","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"5","key":"5219_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/15548627.2017.1390636","volume":"14","author":"J Liu","year":"2018","unstructured":"Liu J, Liu W, Lu Y et al (2018) Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models. Autophagy 14(5):845\u2013861. https:\/\/doi.org\/10.1080\/15548627.2017.1390636","journal-title":"Autophagy"},{"key":"5219_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121023","volume":"309","author":"YY Kuo","year":"2022","unstructured":"Kuo YY, Ho KH, Shih CM et al (2022) Piperlongumine-inhibited TRIM14 signaling sensitizes glioblastoma cells to Temozolomide treatment. Life Sci 309:121023. https:\/\/doi.org\/10.1016\/j.lfs.2022.121023","journal-title":"Life Sci"},{"issue":"1","key":"5219_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02686-1","volume":"42","author":"F Liu","year":"2023","unstructured":"Liu F, Zhou Q, Jiang HF et al (2023) Piperlongumine conquers Temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity. J Exp Clin Cancer Res 42(1):118. https:\/\/doi.org\/10.1186\/s13046-023-02686-1","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"5219_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-025-01211-0","volume":"38","author":"T Trasaktaweesakul","year":"2025","unstructured":"Trasaktaweesakul T, Asavaritikrai P, Talabnin K et al (2025) In vitro properties of four benign meningioma cells derived from WHO grade 1 meningiomas. Hum Cell 38(3):84. https:\/\/doi.org\/10.1007\/s13577-025-01211-0","journal-title":"Hum Cell"},{"key":"5219_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109832","author":"L Rawat","year":"2022","unstructured":"Rawat L, Nayak V (2022) Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4\/P21\/P53 genes and synergizes with doxorubicin in osteosarcoma cells. Chemico-Biol Interact. https:\/\/doi.org\/10.1016\/j.cbi.2022.109832","journal-title":"Chemico-Biol Interact"},{"issue":"9","key":"5219_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098048","volume":"24","author":"TH Lin","year":"2023","unstructured":"Lin TH, Kuo CH, Zhang YS et al (2023) Piperlongumine induces cellular apoptosis and autophagy via the ROS\/AKT signaling pathway in human follicular thyroid cancer cells. Int J Mol Sci 24(9):8048. https:\/\/doi.org\/10.3390\/ijms24098048","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5219_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/15287394.2024.2308801","volume":"87","author":"A Baranoski","year":"2024","unstructured":"Baranoski A, Semprebon SC, Biazi BI et al (2024) Piperlongumine inhibits antioxidant enzymes, increases ROS levels, induces DNA damage and G2\/M cell cycle arrest in breast cell lines. J Toxicol Environ Health A 87(7):294\u2013309. https:\/\/doi.org\/10.1080\/15287394.2024.2308801","journal-title":"J Toxicol Environ Health A"},{"issue":"2","key":"5219_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s12276-021-00560-8","volume":"53","author":"KR Bhattarai","year":"2021","unstructured":"Bhattarai KR, Riaz TA, Kim HR, Chae HJ (2021) The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling. Exp Mol Med 53(2):151\u2013167. https:\/\/doi.org\/10.1038\/s12276-021-00560-8","journal-title":"Exp Mol Med"},{"issue":"2","key":"5219_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/0300891620930789","volume":"107","author":"W Ye","year":"2021","unstructured":"Ye W, Huang Q, Tang T, Qin G (2021) Synergistic effects of Piperlongumine and gemcitabine against KRAS mutant lung cancer. Tumori 107(2):119\u2013124. https:\/\/doi.org\/10.1177\/0300891620930789","journal-title":"Tumori"},{"issue":"9","key":"5219_CR24","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3390\/biomedicines11092442","volume":"11","author":"EY Choi","year":"2023","unstructured":"Choi EY, Han EJ, Jeon SJ et al (2023) Piperlongumine induces apoptosis and cytoprotective autophagy via the MAPK signaling pathway in human oral cancer cells. Biomedicines 11(9):2442. https:\/\/doi.org\/10.3390\/biomedicines11092442","journal-title":"Biomedicines"},{"key":"5219_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.114051","volume":"180","author":"EJ Han","year":"2023","unstructured":"Han EJ, Choi EY, Jeon SJ et al (2023) Piperlongumine induces apoptosis and autophagy via the PI3K\/Akt\/mTOR pathway in KB human cervical cancer cells. Food Chem Toxicol 180:114051. https:\/\/doi.org\/10.1016\/j.fct.2023.114051","journal-title":"Food Chem Toxicol"},{"issue":"7355","key":"5219_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature10167","volume":"475","author":"L Raj","year":"2011","unstructured":"Raj L, Ide T, Gurkar AU et al (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475(7355):231\u2013234. https:\/\/doi.org\/10.1038\/nature10167","journal-title":"Nature"},{"issue":"7","key":"5219_CR27","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.3390\/biomedicines11071967","volume":"11","author":"Y Mitobe","year":"2023","unstructured":"Mitobe Y, Suzuki S, Nakagawa-Saito Y et al (2023) The novel MDM4 inhibitor CEP-1347 activates the p53 pathway and blocks malignant meningioma growth in vitro and in vivo. Biomedicines 11(7):1967. https:\/\/doi.org\/10.3390\/biomedicines11071967","journal-title":"Biomedicines"},{"issue":"19","key":"5219_CR28","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.18632\/oncotarget.2402","volume":"5","author":"JL Roh","year":"2014","unstructured":"Roh JL, Kim EH, Park JY et al (2014) Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer. Oncotarget 5(19):9227\u20139238. https:\/\/doi.org\/10.18632\/oncotarget.2402","journal-title":"Oncotarget"},{"issue":"1","key":"5219_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s44319-023-00026-0","volume":"25","author":"K Liu","year":"2024","unstructured":"Liu K, Zhao C, Adajar RC et al (2024) A beneficial adaptive role for CHOP in driving cell fate selection during ER stress. EMBO Rep 25(1):228\u2013253. https:\/\/doi.org\/10.1038\/s44319-023-00026-0","journal-title":"EMBO Rep"},{"issue":"4","key":"5219_CR30","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s11010-020-04044-7","volume":"476","author":"S Kumar","year":"2021","unstructured":"Kumar S, Agnihotri N (2021) Piperlongumine targets NF-\u03baB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer. Mol Cell Biochem 476(4):1765\u20131781. https:\/\/doi.org\/10.1007\/s11010-020-04044-7","journal-title":"Mol Cell Biochem"},{"issue":"9\u201310","key":"5219_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s10495-019-01553-9","volume":"24","author":"J Mohammad","year":"2019","unstructured":"Mohammad J, Singh RR, Riggle C et al (2019) Jnk inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells. Apoptosis 24(9\u201310):730\u2013744. https:\/\/doi.org\/10.1007\/s10495-019-01553-9","journal-title":"Apoptosis"},{"issue":"11","key":"5219_CR32","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","volume":"43","author":"J Park","year":"2020","unstructured":"Park J, Cho J, Song EJ (2020) Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res 43(11):1144\u20131161. https:\/\/doi.org\/10.1007\/s12272-020-01281-8","journal-title":"Arch Pharm Res"},{"issue":"2","key":"5219_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbrc.2013.01.017","volume":"431","author":"M Jarvius","year":"2013","unstructured":"Jarvius M, Frykn\u00e4s M, D\u2019Arcy P et al (2013) Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells. Biochem Biophys Res Commun 431(2):117\u2013123. https:\/\/doi.org\/10.1016\/j.bbrc.2013.01.017","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"5219_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20130282","volume":"454","author":"M Halasi","year":"2013","unstructured":"Halasi M, Wang M, Chavan TS et al (2013) ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors. Biochem J 454(2):201\u2013208. https:\/\/doi.org\/10.1042\/BJ20130282","journal-title":"Biochem J"},{"issue":"3","key":"5219_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbrc.2018.01.100","volume":"496","author":"E Bosc","year":"2018","unstructured":"Bosc E, Nastri J, Lefort V et al (2018) Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome. Biochem Biophys Res Commun 496(3):961\u2013966. https:\/\/doi.org\/10.1016\/j.bbrc.2018.01.100","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05219-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:12:33Z","timestamp":1759993953000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05219-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5219"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05219-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}